Nathan C. Steinle, MD, and Charles C. Wykoff, MD, PhD
The prevalence of diabetes mellitus continues to increase in the United Stat… Read Article
Pravin U. Dugel, MD
There is no doubt that anti -- VEGF-A monotherapy has revolutionized the tre… Read Article
Victor Gonzalez, MD
In patients with center-involved diabetic macular edema (DME), treatment wit… Read Article
Aleksandra Rachitskaya, MD
Several recent trials have examined novel approaches to the treatment of dia… Read Article
Ehab N. El Rayes, MD, PhD
Recent insights into retinal physiology suggest that the retinal dysfunction… Read Article
Peter K. Kaiser, MD
In a previous article published in Retina Today earlier this year, I provide… Read Article
NEI Award for ‘Retina in a Dish’
A team at the University of Mary… Read Article
Michael A. Singer, MD
img class="left" src="http://retinatoday.com/images/articles/2017-10/Singer_Mich… Read Article
Ferdinand Rodriguez, MD; Joshua D. Levinson, MD; and Jordana G. Fein, MD, MS
img class="left" src="http://retinatoday.com/images/articles/2017-10/Fein_Jordan… Read Article
Positive Phase 3 Results, Regulatory Advances for Spark’s Gene Therapy
… Read Article
Timothy G. Murray, MD, FACS
The increasing incidence and prevalence of diabetes mellitus in the United S… Read Article
Christopher M. Aderman, MD, and Sunir J. Garg, MD
Diabetic macular edema (DME) affects an estimated 746,000 Americans.1 Althou… Read Article
Peter K. Kaiser, MD
Integrins have recently emerged as a treatment target in vitreoretinal disea… Read Article
Pravin U. Dugel, MD
The potential of using an oral vehicle for drug delivery in diseases of the … Read Article
NONVIRAL GENE THERAPY FOR UVEITIS BEGINS CLINICAL TRIAL
A nonviral gene thera… Read Article
Peter A. Karth, MD, MBA, and Ehsan Rahimy, MD
Recently, the terms artificial intelligence (AI) and machine learning have b… Read Article
Caesar K. Luo, MD, and Melissa D. Neuwelt, MD
Continuous wave (CW) laser photocoagulation has been a mainstay in the treat… Read Article
LONGER-TERM DME OUTCOMES PREDICTED BY EARLY RESPONSE TO ANTI-VEGF THERAPY
Eye… Read Article
Mahima Jhingan, MD; Komal Agarwal, MD; and Jay Chhablani, MD
img class="left" src="http://retinatoday.com/images/articles/2017-01/Chhablani_j… Read Article
Aron Shapiro; David Hollander, MD; and Lisa Smith
img class="left" src="http://retinatoday.com/images/articles/2017-01/Smith_Lisa_… Read Article
Stephen G. Schwartz, MD, MBA, and Ingrid U. Scott, MD, MPH
The Diabetic Retinopathy Clinical Research Network (DRCR.net), formed in 200… Read Article
the staff of Retina Today
We are at the tail end of another successful year for the retina world. It is pr… Read Article
Rishi P. Singh, MD, and Ingrid U. Scott, MD, MPH
Although ophthalmologists provide specialized services for patients with dia… Read Article
CMS Releases Proposed 2017 ASC Payment Rates for Ophthalmic Services
The … Read Article
Baruch Kuppermann, MD, PhD
Although the retina subspecialty has largely embraced pharmacology in the tr… Read Article
Sergio Rojas, MD, and Ezequiel Diaz Benitez, MD
Diabetic macular edema (DME) is an important cause of visual loss in patient… Read Article
Nancy M. Holekamp, MD
At one time, laser photocoagulation was the only option for treating patient… Read Article
Brian C. Joondeph, MD, MPS
As physicians, we all know the importance of being reimbursed and paid for s… Read Article
Study: Higher Risk for Neurodevelopmental Disabilities With Bevacizumab for ROP
… Read Article
Jay Chhablani, MD, and Vivek Gupta, MBBS
Advanced surgical techniques have improved the outcomes of cataract surgery … Read Article
Randall V. Wong, MD
Prior to the adoption of intravitreal injections for the treatment of retina… Read Article
RETROSPECTIVE STUDY: L-DOPA WAS PROTECTIVE AGAINST WET AMD
Exogenous L-DOPA… Read Article
The American Academy of Ophthalmology (AAO) 2015 Annual Meeting was held Novem… Read Article
Daniel D. Esmaili, MD; and David S. Boyer, MD
At a Glance
• Intravitreal injection is the current drug delivery meth… Read Article
Scott W. Cousins, MD
As part of this review of sustained-release steroid implants, I will discuss the… Read Article
Yoshihiro Yonekawa, MD; and Jeremy D. Wolfe, MD
The dexamethasone intravitreal implant (Ozurdex, Allergan) is approved by the US… Read Article
Anat Loewenstein, MD
At a Glance
• Although pharmacologic therapy provides excellent result… Read Article
Raj K. Maturi, MD
At a Glance
• Home monitoring of some retinal diseases is desirable be… Read Article
Antonio Capone Jr, MD
At a Glance
• The degree to which VEGF or inflammation is the more imp… Read Article
Karen Roman, Editor-in-Chief
At a Glance
• Anti-VEGF agents can enter the circulation and reduce sy… Read Article
Baruch D. Kuppermann, MD, PhD
At a Glance
• Integrins are cell surface receptors involved in angioge… Read Article
Szilárd Kiss, MD
At a Glance
• It is important to weigh the visual benefits and potenti… Read Article
Bryan Bechtel, Editor-in-Chief
The results of the DRCR.net Protocol T study have been released to the re… Read Article
Dilsher S. Dhoot, MD, and Dante Pieramici, MD
The landscape for the treatment of diabetic macular edema (DME) is evolving. O… Read Article
Nancy Holekamp, MD
Anti-VEGF drugs are appropriately considered first line therapy for patient… Read Article
Sam E. Mansour, MSc, MD, FRCS(C), FACS
Diabetic macular edema (DME) is a leading cause of vision loss among indivi… Read Article
Christopher J. Brady, MD
Screening for diabetic retinopathy (DR) with retinal fundus examination is … Read Article
David Eichenbaum, MD; John W. Kitchens, MD; and Andrew A. Moshfeghi, MD, MBA
There Are Several Ways to Define Treatment Failure
By David Eichenbaum,… Read Article
Paul E. Tornambe, MD, FACS
The rising incidence of diabetes in the US population and the cresting wave of… Read Article
Joint Technical Report Highlights Viability of Telemedicine for ROP Evaluation… Read Article
An Interview with David Eichenbaum, MD
There is now a variety of options for treating patients with diabetic macul… Read Article
Jay Chhablani, MD; Paolo Lanzetta, MD; Adrian Koh, MBBS, MMed (Ophth), FRCS (Ed), FAMS; and Michael …
How fast does the DEX implant reduce macular edema, and in which disease states … Read Article
Aron Shapiro with Michael Tolentino, MD, and Edward Quinlan, MD
What are some qualifying features that identify patients who will work well in a… Read Article
With David S. Boyer, MD
Retina Today: Where do corticosteroid sustained-release devices fit in the treat… Read Article
Diana V. Do, MD
Untreated diabetic macular edema (DME) can lead to vision loss in patients with … Read Article
With Quan Dong Nguyen, MD, MSc
Treatments for diabetic macular edema (DME) continue to be developed. Retina Tod… Read Article
María H. Berrocal, MD
Vitrectomy has evolved in the past 45 years, from very large incisions with Kasn… Read Article
Manish Nagpal, MS, DO, FRCS; Chaitanya Shukla, DNB; and Kartikey Kothari, MS
Since the ETDRS, panretinal photocoagulation (PRP) or macular laser in the form … Read Article
Sahar Al-Husainy, MBChB, FRCS(Ed), MRCOphth; and Jonathan M. Gibson, MB, BS, MD, FRCS(Ed), FRCOphth
In recent years, diabetes mellitus has become a global health problem. In the Un… Read Article
Rahul N. Khurana, MD
Although anti-VEGF monotherapy is effective for treating diabetic macular edema … Read Article
Tarek S. Hassan, MD and Julia A. Haller, MD
These articles are based on the debate-style presentations at the American Acade… Read Article
Sebastien Guigou, MD
Laser photocoagulation is a proven treatment for retinal pathologies and has bee… Read Article
Jay Chhablani, MD; and Aditya Sudhalkar, MD
Fluorescein angiography (FA) and optical coherence tomography (OCT) scans are im… Read Article
